12.Wk1Dis
Surgeon General’s Perspectives
Public Health Reports / January–February 2015 / Volume 130 3
FAMILY HEALTH HISTORY: USING THE PAST TO IMPROVE FUTURE HEALTH
Boris D. Lushniak, MD, MPH, RADM, USPHS
More than a decade after completion of the Human Genome Project,1 science has made substantial prog- ress in the development of genomic tests for disease diagnosis, prognosis, risk prediction, prevention, and treatment. Yet, the simplest, most readily available, and most affordable genomic tool for disease preven- tion—the family health history—remains underused. For almost all diseases of public health significance, people with a family history of the disease have a higher risk of developing the disease than people without a family history. Even so, many people do not collect family health history information and share it with relatives2 or even with their health-care providers.
The year 2014 marked the 10th anniversary of the Surgeon General’s Family Health History Initiative, launched in 2004 by former Surgeon General Dr. Richard Carmona.3 This initiative is a national cam- paign to help families learn more about their family health history. It provides a free Web-based tool, My Family Health Portrait, to help people collect, organize, and record their family health informa- tion. To highlight the importance of this initiative, Dr. Carmona and later Surgeons General have declared Thanksgiving as Family Health History Day.
The collection of family health history information is part of routine health- care interactions and can inform clinical decision making and preventive services. Family health history is a part of many screening and treatment guidelines and, in some cases, can make a big difference in the recommended age for screening. For example, the U.S. Preventive Services Task Force (USPSTF) strongly recommends cholesterol screening beginning at age 35 years for men, but recommends early cholesterol screening beginning at age 20 years for men and women who are at increased risk of cardiovascular disease.4 A family history of cardiovascular disease
before 50 years of age in male relatives, or before 60 years of age in female relatives, is one of several fac- tors that are used to define increased risk. Using these recommendations, about 16% of young adults should be screened earlier based solely on the estimated prevalence of family history of early cardiovascular disease among this age group.5 Likewise, the USPSTF recommends screening for osteoporosis for women aged 65 years or older, but earlier screening for women aged 50–64 years with certain risk factors that include parental history of fracture.6 Thus, a 55-year-old white woman whose parent has had a hip fracture should consider getting screened early because her 10-year risk for major osteoporotic fracture is at least as great as a 65-year-old white woman who has no additional risk factors.
Several other USPSTF recommendations also include family health history information in determin- ing who should be screened or treated and when. For example, the USPSTF recommends that for women with a family history of breast cancer, clinicians con- sider further breast cancer risk assessment to inform shared decision making regarding chemoprevention.7 Likewise, the USPSTF recommends that primary care
4 Surgeon General’s Perspectives
Public Health Reports / January–February 2015 / Volume 130
providers screen women who have family members with breast, ovarian, and other cancers known to be associ- ated with BRCA (BReast CAncer susceptibility genes) mutations using one of several family history-based screening tools to identify those who should receive genetic counseling and, if indicated after counseling, BRCA testing.8
National public health initiatives based on guidelines and recommendations informed by family health history include Healthy People 2020,9 the Diabetes Pre- vention Program,10 and the Million Hearts Initiative.11 With more than 70 million additional Americans receiv- ing preventive services covered under the Affordable Care Act beginning in 2010, these recommendations become all the more important.12
Most people have a family health history of at least one common disease (e.g., cancer, coronary heart disease, and diabetes) or health condition (e.g., high blood pressure and hypercholesterolemia). Preventive services recommendations that incorporate family health history can improve health outcomes for those at increased risk. A recent study demonstrated that systematic collection of family health history increases the proportion of people identified as having high cardiovascular risk for the purposes of targeted pre- vention.13 Similarly, family health history of diabetes has been shown to have added value for detecting undiagnosed diabetes in the U.S. population when combined with other known risk factors.14 But even in cases where family history does not alter specific preventive service recommendations (e.g., the USPSTF recommendations for high blood pressure screening of adults aged 18 years or older, regardless of risk factors such as family history),15 providers who know the patient’s family health history can take this knowledge into consideration during clinical care.
Recent national efforts can help improve the collec- tion and use of family health history information. In 2014, the Stage 2 Medicare Meaningful Use measures for electronic health records (EHRs) took effect, and they included incentives to collect family health history information as structured data.16 In 2008, the Family Health History Multi-Stakeholder Workgroup of the American Health Information Community (AHIC) proposed a core dataset for family health history information and explored approaches to promote the incorporation of such information in EHRs.17 Clinical decision support tools that incorporate family health history information into risk assessment and prevention plans are becoming available to assist with implement- ing existing practice guidelines. The Surgeon General’s My Family Health Portrait has been continually updated since it was initially developed in 2004, including a
redesign in 2009 to be interoperable with EHRs and to collect information consistent with the AHIC mini- mum core dataset. In 2014, My Family Health Portrait was updated to include new risk assessment tools for diabetes and colorectal cancer.
With the growing availability of next-generation genome sequencing, current efforts to develop predictive tests for common chronic diseases have moved toward increasing numbers of common and rare genetic variants. But early studies suggest that these tests will likely complement rather than replace family health history.18,19 Family health history gives information not only about genes, but also about envi- ronmental and behavioral risk factors shared among family members. It therefore can provide a more accurate prediction of disease risk than many genetic tests can alone. During the next decade, research will continue to refine the interconnected roles of family health history and genomic information in screening, treatment, and prevention. In the meantime, enhanced training and education of the public health and clini- cal workforce is needed to realize the health benefits of these discoveries, and everybody needs to become more aware and savvy about the potential value of family health history.
Boris D. Lushniak is the Acting Surgeon General of the United States.
The author thanks Katherine Kolor, PhD, and Muin J. Khoury, MD, PhD, of the Office of Public Health Genomics, Centers for Disease Control and Prevention; and Ridgely Fisk Green, PhD, of Carter Consulting Inc., for their contributions to this article.
REFERENCES 1. Guttmacher AE, Collins FS. Welcome to the genomic era. N Engl
J Med 2003;349:996-8. 2. Awareness of family health history as a risk factor for disease—United
States, 2004. MMWR Morb Mortal Wkly Rep 2004;53(44):1044-7. 3. Department of Health and Human Services (US). Surgeon General’s
family health history initiative [cited 2014 Aug 29]. Available from: URL: http://www.hhs.gov/familyhistory
4. Preventive Services Task Force (US). Screening for lipid disor- ders in adults: recommendation statement. 2008 [cited 2014 Sep 1]. Available from: URL: http://www.uspreventiveservices taskforce.org/Page/Document/RecommendationStatementFinal /lipid-disorders-in-adults-cholesterol-dyslipidemia-screening
5. Kuklina EV, Yoon PW, Keenan NL. Prevalence of coronary heart disease risk factors and screening for high cholesterol levels among young adults, United States, 1999–2006. Ann Fam Med 2010;8:327-33.
6. Preventive Services Task Force (US). Screening for osteopo- rosis: recommendation statement. 2011 [cited 2014 Sep 1]. Available from: URL: http://www.uspreventiveservicestask force.org/Page/Document/RecommendationStatementFinal /osteoporosis-screening
7. Preventive Services Task Force (US). Medications for risk reduc- tion of primary breast cancer in women: U.S. Preventive Services Task Force recommendation statement. 2013 [cited 2014 Sep 1]. Available from: URL: http://www.uspreventiveservicetaskforce .org/Page/Document/RecommendationStatementFinal/breast- cancer-medications-for-risk-reduction
Surgeon General’s Perspectives 5
Public Health Reports / January–February 2015 / Volume 130
8. Preventive Services Task Force (US). Risk assessment, genetic counsel- ing, and genetic testing for BRCA-related cancer in women: U.S. Pre- ventive Services Task Force recommendation statement. 2013 [cited 2014 Sep 1]. Available from: URL: http://www.uspreventiveservices taskforce.org/Page/Document/RecommendationStatement Final /brca-related-cancer-risk-assessment-genetic-counseling-and-genetic- testing-december-2013
9. Department of Health and Human Services (US). Healthy People 2020 genomics objective G-1 [cited 2014 Aug 29]. Available from: URL: http://www.healthypeople.gov/2020/topicsobjectives2020 /objectiveslist.aspx?topicId=15
10. Albright AL, Gregg EW. Preventing type 2 diabetes in communities across the U.S.: the National Diabetes Prevention Program. Am J Prev Med 2013;44(4 Suppl 4):S346-51.
11. Frieden TR, Berwick DM. The “Million Hearts” initiative—prevent- ing heart attacks and strokes. N Engl J Med 2011;365:e27.
12. Skopec L, Sommers BD. Seventy-one million additional Americans are receiving preventive services coverage without cost-sharing under the Affordable Care Act. Rockville (MD): Department of Health and Human Services (US); 2013. Also available from: URL: http://aspe .hhs.gov/health/reports/2013/PreventiveServices/ib_prevention .cfm [cited 2014 Oct 6].
13. Qureshi N, Armstrong S, Dhiman P, Saukko P, Middlemass J, Evans PH, et al. Effect of adding systematic family history enquiry to car- diovascular disease risk assessment in primary care: a matched-pair, cluster randomized trial. Ann Intern Med 2012;156:253-62.
14. Yang Q, Liu T, Valdez R, Moonesinghe R, Khoury MJ. Improvements in ability to detect undiagnosed diabetes by using information on family history among adults in the United States. Am J Epidemiol 2010;171:1079-89.
15. Preventive Services Task Force (US). Screening for high blood pressure: reaffirmation recommendation statement. 2007 [cited 2014 Sep 1]. Available from: URL: http://www.uspreventiveservices taskforce.org/uspstf07/hbp/hbprs.htm
16. Centers for Medicare & Medicaid Services (US). Stage 2 eligible professional meaningful use menu set measures: measure 4 of 6 [cited 2014 Aug 29]. Available from: URL: http://www.cms.gov /Regulations-and-Guidance/Legislation/EHRIncentivePrograms /downloads/Stage2_EPMenu_4_FamilyHealthHistory.pdf
17. Feero WG, Bigley MB, Brinner KM; the Family Health History Multi-Stakeholder Workgroup of the American Health Information Community. New standards and enhanced utility for family health history information in the electronic health record: an update from the American Health Information Community’s Family Health History Multi-Stakeholder Workgroup. J Am Med Inform Assoc 2008;15:723-8.
18. Park JH, Gail MH, Greene MH, Chatterjee N. Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers. J Clin Oncol 2012;30:2157-62.
19. Heald B, Edelman E, Eng C. Prospective comparison of family medical history with personal genome screening for risk assessment of common cancers. Eur J Hum Genet 2012;20:547-51.